A Study to Assess the Pain Perception during Administration of Intramuscular Injection of Benzathine Penicillin with cold needle in Rheumatic Heart Disease Patients.

A Study to Assess the Effect of Temperature of Needle on Perception of Pain during Administration of Intramuscular Injection of Benzathine Penicillin to Patients Having Rheumatic Heart Disease

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009501

Enrollment

100

Registered

2017-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Rheumatic Heart Disease Patients receiving Benzathine Penicillin Injection every 3 weekly

Interventions

Intervention1: Using cold needle(0-2 degree Celsius): Using cold needle(0-2 degree Celsius) to administer intramuscular benzathine penicillin injection Control Intervention1: Room temperature needle:

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients and parents giving informed consent. 2.Patients receiving benzathine penicillin intramuscular injection every 21 days and capable of giving adequate response. 3.Absence of any problem/ conditions resulting in pain.

Exclusion criteria

Exclusion criteria: 1.Muscular dystrophies 2.Disoriented patients 3.Diabetic neuropathy

Design outcomes

Primary

Measure	Time frame
subjective pain perception when administering intramuscular penicillin injection using cold needle as compared to room temperature needle as assessed by numerical rating scaleTimepoint: Immediately after administering injection	—

Secondary

Measure	Time frame
Change in objective pain assessment(Blood Pressure and Pulse) when cold needle was used compared to room temperatureTimepoint: Five minutes before and after administering intramuscular injection	—

Countries

India

Contacts

Public ContactNisha Thomas

AIIMS New Delhi

rjuneja2@gmail.com9899614420

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026